Circulating anti‐glutamic acid decarboxylase‐65 antibody titers are positively associated with the capacity of insulin secretion in acute‐onset type 1 diabetes with short duration in a Japanese population
Open Access
- 27 March 2019
- journal article
- research article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 10 (6) , 1480-1489
Abstract
Aims/Introduction: To elucidate the relationship between titers of islet autoantibodies, the C‐X‐C motif chemokine 10 – a circulating chemokine that activates T‐helper 1 cells leading to β‐cell destruction – and β‐cell function in type 1 diabetes.Materials and Methods: In total, 58 type 1 diabetes patients positive for glutamic decarboxylase‐65 autoantibodies (GADA)‐radioimmunoassay (mean age 54.1 years; 27 acute‐onset cases and 31 slowly progressive cases) were enrolled; serum C‐X‐C motif chemokine 10 (n = 50), zinc transporter 8 autoantibodies (n = 50) and GADA (n = 58) by an enzyme‐linked immunosorbent assay, and insulinoma‐associated antigen‐2 autoantibodies by radioimmunoassay (n = 50) were measured. The ratio of 100 × random C‐peptide (ng/mL)‐to‐plasma glucose levels (mg/dL; C‐peptide index [CPI]) was measured.Results: The CPI significantly decreased in both groups with the progression of disease duration. GADA titers by radioimmunoassay and enzyme‐linked immunosorbent assay were strongly correlated with the CPI in acute‐onset type 1 diabetes patients with a shorter disease duration (≤10 years), but not in those with a longer duration or slowly progressive type 1 diabetes. Neither insulinoma‐associated antigen‐2 nor zinc transporter 8 autoantibodies titers were correlated with the CPI. Serum C‐X‐C motif chemokine 10 levels in both groups were significantly higher than in non‐diabetic controls, and persisted at high levels even in those with chronic duration.Conclusions: Among islet autoantibodies, the intensity of the humoral immune response, as defined by GADA titers, reflected the degree of residual β‐cell function in acute‐onset type 1 diabetes patients with short duration. Prolonged disease activity might accelerate β‐cell impairment in both subtypes of type 1 diabetes.Keywords
This publication has 42 references indexed in Scilit:
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsJournal of Experimental Medicine, 2012
- Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patientsClinical and Experimental Immunology, 2011
- Prediction of Type 1 Diabetes in the General PopulationDiabetes Care, 2010
- Functional Assessment of Pancreatic β-Cell Area in HumansDiabetes, 2009
- The Role of the CXCL10/CXCR3 System in Type 1 DiabetesThe Review of Diabetic Studies, 2009
- Two Cases of “Fulminant” Type 1 Diabetes Suggesting Involvement of AutoimmunityAnnals of the New York Academy of Sciences, 2003
- High Levels of Antigen-Specific Islet Antibodies Predict Future -Cell Failure in Patients with Onset of Diabetes in Adult AgeThe Journal of Clinical Endocrinology & Metabolism, 2001
- Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.Journal of Clinical Investigation, 1998
- Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagonDiabetologia, 1977